"Caliciviridae Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Virus diseases caused by CALICIVIRIDAE. They include HEPATITIS E; VESICULAR EXANTHEMA OF SWINE; acute respiratory infections in felines, rabbit hemorrhagic disease, and some cases of gastroenteritis in humans.
Descriptor ID |
D017250
|
MeSH Number(s) |
C02.782.160
|
Concept/Terms |
Caliciviridae Infections- Caliciviridae Infections
- Infections, Caliciviridae
- Caliciviridae Infection
- Infection, Caliciviridae
Norovirus Infections- Norovirus Infections
- Infection, Norovirus
- Infections, Norovirus
- Norovirus Infection
|
Below are MeSH descriptors whose meaning is more general than "Caliciviridae Infections".
Below are MeSH descriptors whose meaning is more specific than "Caliciviridae Infections".
This graph shows the total number of publications written about "Caliciviridae Infections" by people in this website by year, and whether "Caliciviridae Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1996 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2000 | 2 | 3 | 5 |
2001 | 2 | 1 | 3 |
2002 | 1 | 1 | 2 |
2003 | 1 | 0 | 1 |
2004 | 3 | 1 | 4 |
2005 | 1 | 0 | 1 |
2006 | 5 | 0 | 5 |
2007 | 2 | 0 | 2 |
2008 | 1 | 0 | 1 |
2009 | 5 | 0 | 5 |
2010 | 5 | 1 | 6 |
2011 | 4 | 0 | 4 |
2012 | 1 | 0 | 1 |
2013 | 3 | 0 | 3 |
2014 | 5 | 1 | 6 |
2015 | 10 | 0 | 10 |
2016 | 8 | 0 | 8 |
2017 | 4 | 1 | 5 |
2018 | 3 | 0 | 3 |
2019 | 5 | 3 | 8 |
2020 | 7 | 0 | 7 |
2021 | 4 | 3 | 7 |
2022 | 4 | 0 | 4 |
2023 | 5 | 0 | 5 |
2024 | 3 | 3 | 6 |
2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Caliciviridae Infections" by people in Profiles.
-
Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. J Virol. 2025 Feb 25; 99(2):e0175724.
-
2'-Fucosyllactose inhibits human norovirus replication in human intestinal enteroids. J Virol. 2025 Feb 25; 99(2):e0093824.
-
RNA-dependent RNA polymerase of predominant human norovirus forms liquid-liquid phase condensates as viral replication factories. Sci Adv. 2024 Dec 20; 10(51):eadp9333.
-
Correlation of Genogroup I, Genotype 1 (GI.1) Norovirus Neutralizing Antibody Levels With GI.1 Histo-Blood Group Antigen-Blocking Antibody Levels. J Infect Dis. 2024 Dec 16; 230(6):1376-1379.
-
Norovirus acute gastroenteritis amongst US and European travellers to areas of moderate to high risk of travellers' diarrhoea: a prospective cohort study. J Travel Med. 2024 Oct 19; 31(7).
-
Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 Nov 21; 9(11):e0044824.
-
Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition. J Virol. 2024 Jul 23; 98(7):e0202023.
-
A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. J Infect Dis. 2024 May 15; 229(5):1402-1407.
-
N-glycoproteomic analyses of human intestinal enteroids, varying in histo-blood group geno- and phenotypes, reveal a wide repertoire of fucosylated glycoproteins. Glycobiology. 2024 04 24; 34(6).
-
A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity. Nat Commun. 2023 10 16; 14(1):6516.